5hbx	A	14	1.7		URS0002681414_32630	28058281					32630	nnnnacuuaagucu	..............	..............	RNA primer-template complex with 2-methylimidazole-activated monomer analogue-2 binding sites; RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG)P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3')
5hbx	B	14	1.7		URS0002681414_32630	28058281					32630	nnnnacuuaagucu	..............	..............	RNA primer-template complex with 2-methylimidazole-activated monomer analogue-2 binding sites; RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG)P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3')
5hbx	C	14	1.7		URS0002681414_32630	28058281					32630	nnnnacuuaagucu	..............	..............	RNA primer-template complex with 2-methylimidazole-activated monomer analogue-2 binding sites; RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG)P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3')
5hbx	D	14	1.7		URS0002681414_32630	28058281					32630	nnnnacuuaagucu	..............	..............	RNA primer-template complex with 2-methylimidazole-activated monomer analogue-2 binding sites; RNA (5'-R(*(LCC)P*(LCC)P*(LCA)P*(LCG)P*AP*CP*UP*UP*AP*AP*GP*UP*CP*U)-3')
5hby	A	13	1.18			28058281					32630	nnnnacuuaaguc	.............	.............	RNA primer-template complex with 2-methylimidazole-activated monomer analogue-3 binding sites; RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG)P*AP*CP*UP*UP*AP*AP*GP*UP*C)-3')
5krg	B	15	1.6			28058281					32630	nnnnacuuaagucgg	...............	...............	RNA 15mer duplex binding with PZG monomer; RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG)P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3')
5krg	D	15	1.6			28058281					32630	nnnnacuuaagucgg	...............	...............	RNA 15mer duplex binding with PZG monomer; RNA (5'-R(*(LCC)P*(LCC)P*(LCC)P*(LCG)P*AP*CP*UP*UP*AP*AP*GP*UP*CP*GP*G)-3')